Edwards Lifesciences – (NYSE:EW)

Finance December 10, 2015

Breaking: Edwards Lifesciences (NYSE:EW) “Equal Weight” Rating Restated by research analysts Barclays Today; The TP is $170.0

Edwards Lifesciences (NYSE:EW) Rating Reaffirmed Research analysts at Barclays now has a $170.0 PT on Edwards Lifesciences (NYSE:EW). Barclays and their recent PT suggests a…

Finance December 10, 2015

Key Investment Analysts at Barclays Reconfirmed their ‘Equal Weight’ rating for Edwards Lifesciences (NYSE:EW) Shares Today. Their Price Objective is $170

Edwards Lifesciences (NYSE:EW) Rating Reaffirmed They currently have a $170 target price on Edwards Lifesciences (NYSE:EW). The target price by Barclays would suggest a potential…